相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives
Cristina Birzu et al.
CANCERS (2021)
Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study
Rebecca M. Hill et al.
LANCET CHILD & ADOLESCENT HEALTH (2020)
Medulloblastoma
Paul A. Northcott et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Tanvi Sharma et al.
ACTA NEUROPATHOLOGICA (2019)
Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas
Ji Hoon Phi et al.
ACTA NEUROPATHOLOGICA (2018)
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort
Sebastian M. Waszak et al.
LANCET ONCOLOGY (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
Edward C. Schwalbe et al.
LANCET ONCOLOGY (2017)
The whole-genome landscape of medulloblastoma subtypes
Paul A. Northcott et al.
NATURE (2017)
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M. G. Cavalli et al.
CANCER CELL (2017)
Divergent clonal selection dominates medulloblastoma at recurrence
A. Sorana Morrissy et al.
NATURE (2016)
Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease
Rebecca M. Hill et al.
CANCER CELL (2015)
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
Giles W. Robinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies
Edward C. Schwalbe et al.
ACTA NEUROPATHOLOGICA (2013)
Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions using Hidden Markov Models
Hashem A. Shihab et al.
HUMAN MUTATION (2013)
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
Nataliya Zhukova et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
Vijay Ramaswamy et al.
LANCET ONCOLOGY (2013)
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool et al.
ACTA NEUROPATHOLOGICA (2012)
A Combined Functional Annotation Score for Non-Synonymous Variants
Margarida C. Lopes et al.
HUMAN HEREDITY (2012)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
TP53 Mutations in Favorable-Risk Wnt/Wingless-Subtype Medulloblastomas
Janet C. Lindsey et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials
Barry L. Pizer et al.
BRITISH JOURNAL OF NEUROSURGERY (2009)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
